AMCP CEO Blog: AMCP’s roughly 8,000 members work diligently every day to improve patient care through the optimized use of medicines. As an organization, we also take a leading role in developing improvements to the overall delivery of care, which is no easy task given the size and complexity of our health care system.
AMCP Submits Comments to Senate Finance Committee on Drug Pricing Bill HHS Announces Action Plan for Safe Importation of Prescription Drugs; CMS Issues 2020 Physician Fee Schedule; AMCP Submits Comments on Reducing Administrative Burdens in Health Care
White House Withdraws ‘Rebate Rule’; House Holds Hearings and Markups on Bills Addressing Drug Pricing Transparency; CMS Issues New Proposed Rule on ePA; CMS Seeks Comments on Reducing Administrative Burdens in Health Care AMCP Takes Steps to Improve Prior Authorization on Processes
Senate Drug Pricing Bill Unveiled; House Passes CREATES Act; AMCP Comments on Biosimilar and Interchangeable Insulin Products; AMCP Comments on Proposed Rule on Information Blocking; CMS Issues RFI on Reducing Administrative Burden to 'Put Patients Over Paperwork'; AMCP’s PA and UM Concepts in Managed Care Pharmacy Is Available in JMCP
Recent House Activities; Eye on the States; Nonproprietary Naming of Biological Products; Interchangeability with Reference Product; Drug Price Transparency in Medicare & Medicaid; PA and UM Concepts in Managed Care Pharmacy
August 2019 News & Views: Read articles about AMCP’s new website, board of directors meeting, AMCP Diplomat spotlight, the Nexus 2019 General Session keynote speaker, and much more.
Press Release: AMCP comments in joint statement on the Administration’s latest initiative to modernize substance use disorder (SUD) treatment privacy law and enhance coordinated care and safety.
